Enteral Feeding Formulas Market Size Worth $13.81 Billion By 2032 | CAGR: 8.00%

Enteral Feeding Formulas Market Size Worth $13.81 Billion By 2032 | CAGR: 8.00%

The global enteral feeding formulas market size is expected to reach USD 13.81 billion by 2032, according to a new study by Polaris Market Research. The report Enteral Feeding Formulas Market Share, Size, Trends, Industry Analysis Report, By Products (Standard formula, Disease-Specific Formulas); By Flow Type; By Tube Type; By Indication; By End-Use; By Distribution Channels; By Region, And Segment Forecasts, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for enteral feeding formula is predominantly propelled by the growing prevalence of chronic and metabolic disorders, escalating patient care expenditures, and the expanding senior population. As per IDF 2021, around 537 million adults are presently living with diabetes, and this number is projected to increase in the coming years, which is anticipated to boost market growth. The upsurge in metabolic diseases is predicted to propel market growth due to the mounting adoption of diabetic patients of enteral feeds. The specific nutrition formulas for Diabetes (DSNFs) can aid in controlling the severity, progression, and development of specific chronic diseases.

As effective supportive care is crucial in managing critically ill patients with COVID-19, the enteral feeding formula market is expected to be impacted by the outbreak. Within this care, nutritional management of COVID-19 patients admitted to the ICU is essential. A study published in Nutrients in March 2022 emphasized the importance of prompt enteral nutrition support and sufficient nutrients to prevent malnutrition among individuals with COVID-19.

In addition, enteral feeding assistance is recommended for critically ill patients, which may have contributed to the growth of the enteral feeding formula market during the pandemic. Moreover, after the pandemic, there has been a surge in demand for these formulas due to various factors, such as the rise in the prevalence of diseases, an increase in the number of hospitals, and a growing need for enteral feeding formulas.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/enteral-feeding-formulas-market/request-for-sample

The aging population mainly drives the enteral feeding formula market. The demand for enteral nutrition is expected to increase with the growing number of elderly individuals adopting enteral feeding formulas. Additionally, the rising healthcare expenditure in both developed and developing countries and the increasing demand for home healthcare services are expected to contribute to the growth of the enteral feeding formula market.

In addition, the market growth is expected to be driven by the increasing number of product launches by key market players. For example, in May 2022, Abbott announced the launch of EleCare, a specialty amino acid-based formula for infants and children with severe food allergies or gastrointestinal (GI) disorders, which is expected to drive market growth through increased adoption in pediatrics. However, the enteral feeding formula market may need to be improved by complications associated with enteral nutrition, high costs, and low adherence rates in developing countries.

Enteral Feeding Formulas Market Report Highlights

  • Due to several factors, the standard formulas segment is expected to account for the largest enteral feeding formula market share during the forecast period. Standard formulas are the most commonly used enteral feeding formula recommended for patients without specific nutritional needs. Also, the growing geriatric population and rising prevalence of chronic diseases are expected to drive demand for standard formulas.
  • The intermittent feeding flow segment is expected to account for the highest revenue share during the forecast period in the enteral feeding formula market due to its ease of administration, which allows patients to receive nutrients in a controlled manner over a specific period. Intermittent feeding also minimizes the risk of aspiration and other complications associated with continuous feeding.
  • The high demand for enteral feeding formulas in North America is due to several factors. The region's large geriatric population requires enteral feeding formulas for nutritional needs. The rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders in North America has also increased the demand for enteral feeding formulas.
  • During the forecast period, the enteral feeding formulas market is anticipated to be dominated by the Asia Pacific region, primarily due to its sizable population, a growing number of patients with chronic diseases, and increasing incidence of malnutrition.

Polaris Market Research has segmented Enteral Feeding Formulas market report based on product, flow type, tube type, indication, end-use, distribution channels, and region:

Enteral Feeding Formulas, Product Outlook (Revenue - USD Billion, 2019-2032)

  • Standard Formulas
    • Polymeric
    • Monomeric
  • Disease-Specific Formulas
    • Diabetic
    • Renal
    • Hepatic
    • Pulmonary
    • Others

Enteral Feeding Formulas, Flow Type Outlook (Revenue - USD Billion, 2019-2032)

  • Intermittent feeding flow
  • Continuous feeding flow

Enteral Feeding Formulas, Tube Type Outlook (Revenue - USD Billion, 2019-2032)

  • Nasogastric Tube
  • Naso-jejunal tube (NJT)
  • Jejunostomy Tubes
  • Radiologically inserted Gastronomy Tubes (RIG)
  • Percutaneous Endoscopic Gastronomy Tubes (PEG)

Enteral Feeding Formulas, Indication Outlook (Revenue - USD Billion, 2019-2032)

  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

Enteral Feeding Formulas, End-Use Outlook (Revenue - USD Billion, 2019-2032)

  • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
  • Long-term Care Facilities
    • Homecare Agencies & Hospices
    • Nursing Homes
    • Assisted Living Facilities

Enteral Feeding Formulas, Distribution Channels Outlook (Revenue - USD Billion, 2019-2032)

  • Online Sales
  • Institutional Sales
  • Retail Sales

Enteral Feeding Formulas, Regional Outlook (Revenue - USD Billion, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing